Neuropsychologist Advisory Board Member

Alzheimer's Treatment Centers of America; United States; Hybrid; USD 100,000 - 140,000; Part time

Benefits offered by this job

Equity participation opportunities

Engagement in strategic initiatives

Advisory role flexibility

Job summary

A leading cognitive health organization in the United States is seeking an experienced professional to provide neuropsychological governance and diagnostic oversight for their innovative care models. The ideal candidate will have a doctoral degree in psychology and significant experience in cognitive health. Responsibilities include shaping treatment frameworks, ensuring quality standards, and integrating AI technologies into clinical practices. This role offers a unique opportunity to influence the future of brain health care while maintaining the highest standards of excellence.

Qualifications

• Doctoral degree in psychology or a related field is essential.
• Proven experience in neuropsychology with a focus on cognitive disorders.
• Strong communication skills to facilitate interdisciplinary collaboration.
• Expertise in program development and quality assurance in health settings.

Responsibilities

• Provide leadership in neuropsychological assessments and diagnostics.
• Advise on the design and replication of cognitive care models.
• Develop outcomes measurement and quality standards in cognitive care.
• Collaborate with health system leadership for patient-centered care delivery.
• Oversee the integration of innovative technologies in cognitive workflows.

Skills

Neuropsychological assessment

Diagnostic oversight

Program scalability

Quality assurance

Interdisciplinary collaboration

AI technology integration

Education

Doctoral degree in psychology or equivalent

Tools

Electronic Health Records (EHR)

Cognitive assessment tools

Remote monitoring platforms

Job description

About Alzheimer’s Treatment Centers of America (ATCA)

Alzheimer’s Treatment Centers of America (ATCA) leverages Artificial Intelligence (AI) and Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and cognitive impairment, including brain fog associated with Long COVID.

This is about delivering structured, data-driven treatment to patients today. ATCA goes beyond traditional diagnosis to identify underlying contributors to neurodegeneration and cognitive dysfunction, implementing individualized treatment protocols designed to slow progression and improve functional outcomes.

Our multidisciplinary leadership team includes experienced healthcare executives, neuroscientists, AI engineers, and clinical specialists working together to deploy a scalable, neurologist-supported clinic model nationwide. As we expand, we are building a governance framework supported by senior physician leaders and neurocognitive experts who understand clinical rigor, operational scalability, and health system integration.

Why Now?

Growing Community Need: Our Palm Beach Gardens/Jupiter clinic is fully operational and actively treating patients in a high visibility medical corridor adjacent to Cleveland Clinic. Originally launched in a former urgent care space to enable rapid deployment, the clinic reached capacity quickly, with appointments booked months in advance, reflecting significant unmet demand for proactive cognitive care.

Three additional clinics are in development, with broader national expansion underway. ATCA is building a repeatable, specialist-supported specialty model that expands access to structured cognitive evaluation and longitudinal management while maintaining clinical rigor and operational scalability.

Seamless System Integration: ATCA’s care model integrates within the existing healthcare ecosystem. Treatments are reimbursed by Medicare, Medicare Advantage, and most major commercial insurers, reducing barriers to access and accelerating patient adoption.

Focused on Outcomes: In a study utilizing ATCA’s AI driven protocol, 75% of patients with mild cognitive impairment demonstrated no further cognitive decline. This represents a data-driven, proactive approach that complements traditional management pathways and emphasizes measurable outcomes.

Advanced Therapeutic Options: Eligible patients may have access to TB006, an FDA-approved therapy available for compassionate use, providing a potential treatment pathway for certain dementias, including Alzheimer’s disease.

Physician Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. As we expand nationally, we are strengthening this advisory infrastructure with senior clinical leaders who bring expertise in diagnostic rigor, quality assurance, scalability, and systems-based cognitive care delivery.

Key Achievements

Proprietary AI Precision Engine: ATCA has built and deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long term data network effects.

High Margin, Replicable Clinic Model: Engineered a scalable specialty clinic platform targeting 44% EBITDA margins, driven by optimized staffing ratios, high-acuity service mix, and strong reimbursement dynamics designed for rapid multi-market expansion.

Massive, Underserved Market Opportunity: Positioned to capture share in a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, addressing one of the largest and fastest-growing unmet needs in healthcare.

Embedded Revenue Generating Research Infrastructure: Integrated micro-research capabilities within each clinic to generate real-world evidence, pharmaceutical partnerships, clinical trial participation, and recurring high-margin ancillary revenue streams.

Responsibilities Include

Clinical Governance & Diagnostic Oversight: Provide board-level advisory leadership to support standardized neuropsychological assessment frameworks across MCI, Alzheimer’s disease, dementia syndromes, and related cognitive disorders; help ensure diagnostic quality, test interpretation consistency, functional assessment integrity, and evidence-based neurocognitive evaluation standards aligned with recognized best practices.

Programmatic Scalability & Service Line Architecture: Advise executive leadership on the design and replication of high-performing cognitive care models, including neuropsychological evaluation workflows, longitudinal reassessment pathways, multidisciplinary memory clinic integration, referral triage systems, and scalable neurocognitive service delivery platforms that enable regional and national expansion without compromising quality.

Quality, Data & Outcomes Strategy: Guide the development of longitudinal cognitive outcomes measurement, psychometric quality standards, diagnostic accuracy benchmarking, functional status tracking, progression monitoring, patient-reported outcomes, and enterprise reporting frameworks aligned with evidence-based cognitive care and measurable clinical performance.

Executive & Interdisciplinary Alignment: Partner with health system leadership, neurology, geriatrics, psychiatry, primary care, speech and occupational therapy, social work, rehabilitation specialists, and advanced practice providers to ensure coordinated, patient-centered brain health care delivery across outpatient clinics and integrated specialty settings.

Technology & Innovation Stewardship: Provide strategic oversight on the responsible adoption of computerized cognitive tools, remote monitoring platforms, AI-enabled risk stratification models, digital symptom tracking, EHR-integrated cognitive workflows, and emerging diagnostic technologies to strengthen innovation while safeguarding psychometric validity, clinical judgment, and patient safety.

Health System Strategy & Reimbursement Alignment: Advise on positioning neuropsychology within expanding cognitive care programs and integrated health systems; provide insight into reimbursement strategy, documentation standards, coding optimization, referral pathway design, access expansion, and the role of neuropsychological services in sustainable longitudinal brain health models.

Strategic Risk & Growth Advisory: Offer insight on governance maturity, credentialing and quality standards, documentation integrity, medico-legal considerations, capacity and functional assessment safeguards, reputational risk mitigation, multisite clinic expansion, and sustaining clinical excellence and academic credibility during accelerated growth and enterprise scaling.

Why Join Us?

Strategic Influence: Shape the governance architecture of rapidly expanding AI enabled brain health platforms.

Board Level Engagement: Contribute at the advisory level without day to day operational responsibility.

Impact at Scale: Help ensure innovative cognitive care models expand responsibly while preserving the highest standards of diagnostic rigor and neuropsychological integrity.

Enterprise-Level Perspective: Apply neuropsychology leadership experience to one of the most urgent and fastest-growing areas in healthcare.

Clinical Integrity During Innovation: Safeguard rigor, accountability, and patient safety as precision medicine platforms scale nationally.

Equity Participation Opportunities: Select advisory roles may include equity options aligned with long term strategic contribution.

Strategic Investment Access: Advisory members may be offered optional participation in growth financing initiatives where applicable.

Equal Opportunity Commitment

We are committed to fostering inclusive advisory leadership. Diverse perspectives strengthen governance, innovation, and patient outcomes. Senior surgeons from all backgrounds are encouraged to participate in shaping the future of structured, scalable brain health care.